Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interleukin 6 Receptor Blockade for Relapse Prevention in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

JAMA neurology·2026
Same author

Electrodiagnostic Studies as a Diagnostic and Prognostic Tool in Acute Flaccid Myelitis.

Muscle & nerve·2026
Same author

Application of the 2024 McDonald Criteria in Individuals With Nonspecific Symptoms or Incidental Imaging Findings in a Multicenter Study.

Neurology·2026
Same author

High-dose <i>N</i>-acetyl cysteine reduces GFAP levels: Exploratory results from a pilot double-blind, placebo-controlled randomized trial.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Adenotonsillectomy is associated with increased risk and disease activity in pediatric-onset multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

The gut microbiome in pediatric-onset acquired demyelinating syndromes by myelin oligodendrocyte glycoprotein antibody status.

Multiple sclerosis and related disorders·2026

Related Experiment Video

Updated: Jul 2, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Pediatric multiple sclerosis.

Dorothee Chabas1, Jonathan Strober, Emmanuelle Waubant

  • 1University of California, San Francisco, Regional Pediatric Multiple Sclerosis Center, 350 Parnassus Avenue, Suite 908, San Francisco, CA 94117, USA. dorothee.chabas@ucsf.edu

Current Neurology and Neuroscience Reports
|August 21, 2008
PubMed
Summary

Diagnosing pediatric multiple sclerosis (MS) is difficult due to overlapping symptoms with other conditions. Children with MS face unique challenges, including different MRI findings and slower disability progression, yet often receive unproven adult treatments.

More Related Videos

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

Related Experiment Videos

Last Updated: Jul 2, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy
07:20

Repeated Transcranial Magnetic Stimulation Combined with Action Observation Training in Children with Spastic Cerebral Palsy

Published on: August 9, 2024

Area of Science:

  • Neurology
  • Pediatrics
  • Immunology

Background:

  • Diagnosing pediatric multiple sclerosis (MS) presents unique challenges compared to adults, stemming from limited diagnostic criteria and symptom overlap with acute disseminated encephalomyelitis.
  • Pediatric MS often manifests with distinct clinical and radiological features, including a higher prevalence of male patients, seizures, brainstem/cerebellar involvement, and specific MRI findings like posterior fossa lesions.

Purpose of the Study:

  • To highlight the diagnostic difficulties and clinical characteristics of pediatric-onset multiple sclerosis.
  • To underscore the implications of delayed diagnosis and the current treatment landscape for children with MS.

Main Methods:

  • Review of clinical presentation, diagnostic criteria, and MRI findings in pediatric-onset multiple sclerosis.
  • Comparison of pediatric MS characteristics with adult-onset MS.
  • Analysis of disease progression, treatment approaches, and clinical trial limitations in pediatric MS.

Main Results:

  • Pediatric MS patients exhibit differences from adults, such as male predominance, seizures, and brainstem/cerebellar symptoms, with less frequent spinal cord involvement.
  • Initial brain MRIs in prepubertal children may show posterior fossa involvement and less defined, more confluent lesions that resolve over time.
  • Despite slower disability progression, pediatric MS leads to significant disability at a younger age, with potential disparities in non-white populations.

Conclusions:

  • Pediatric-onset multiple sclerosis requires specialized diagnostic considerations due to its unique presentation and imaging features.
  • The rarity of pediatric MS limits clinical trial participation, leading to off-label use of adult therapies with unknown efficacy and tolerability in children.
  • Further research and dedicated clinical trials are crucial to improve diagnosis, treatment, and outcomes for children with multiple sclerosis.